Ustekinumab-Associated Thrombocytopenia in a Patient With Refractory Crohn's Disease

被引：0
|
作者：
Levine, Irving [1 ]
Rolston, Vineet [2 ]
Papademetriou, Marianna [3 ]
Malter, Lisa [2 ]
机构：
[1] NYU, Sch Med, New York, NY USA
[2] NYU, Sch Med, New York, NY USA
[3] Georgetown Univ, Vet Adm, Washington, DC USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2018年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2044
引用
收藏
页码：S1166 / S1166
页数：1
相关论文
共 50 条
  • [31] Successful Drug Desensitization to Ustekinumab in a Patient with Crohn's Disease
    Cohen, Barrie
    Tomer, Gitit
    Gavrilova, Tatyana
    CASE REPORTS IN GASTROENTEROLOGY, 2021, 15 (02) : 657 - 661
  • [32] Morphea in a Crohn's disease patient undergoing ustekinumab treatment
    Makihara-Inukai, Misako
    Takeichi, Takuya
    Ogawa-Momohara, Mariko
    Muro, Yoshinao
    Akiyama, Masashi
    EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31 (01) : 96 - 97
  • [33] Paradoxical pustular psoriasis induced by ustekinumab in a patient with Crohn’s disease-associated spondyloarthropathy
    Michael Benzaquen
    Benoit Flachaire
    Frank Rouby
    Philippe Berbis
    Sandrine Guis
    Rheumatology International, 2018, 38 : 1297 - 1299
  • [34] Vasculitis in a patient with refractory Crohn's disease
    Christina, Silveira Mabel
    Gustavo, Vilar
    Antonio, Balestrim Filho
    Joaquim, Rocha Jose
    Omar, Feres
    Marley, Feitosa
    Rogerio, Parra
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S11 - S11
  • [35] Paradoxical pustular psoriasis induced by ustekinumab in a patient with Crohn's disease-associated spondyloarthropathy
    Benzaquen, Michael
    Flachaire, Benoit
    Rouby, Frank
    Berbis, Philippe
    Guis, Sandrine
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (07) : 1297 - 1299
  • [36] Upadacitinib and ustekinumab combination treatment for a refractory case of spondyloarthritis and Crohn's disease
    Bianchi, E.
    Pata, A. P.
    Cantarini, L.
    Frediani, B.
    Gentileschi, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (03) : 766 - 766
  • [37] Dual biologic therapy with Vedolizumab and Ustekinumab for refractory Crohn's disease in children
    Howard, Gadi
    Weiner, Dror
    Bar-Or, Itzhak
    Levine, Arie
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (04) : 372 - 374
  • [38] Ustekinumab dose escalation improves clinical responses in refractory Crohn's disease
    Haider, Syedreza A.
    Yadav, Abhijeet
    Perry, Courtney
    Su, Leon
    Akanbi, Olalekan
    Kudaravalli, Praneeth
    Tripathi, Nishant
    Hashim, Mahmoud A.
    Abdelsalam, Mohammed
    Hussein, Mohamed
    Elkheshen, Ahmed
    Patel, Vihang
    Ali, Saad Emhmed
    Lamb, Latoya
    Ingram, Karen
    Mayne, Casie
    Stuffelbeam, Amy B.
    Flomenhoft, Deborah
    Stromberg, Arnold
    Barrett, Terrence A.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [39] REAL WORLD EFFECTIVENESS OF USTEKINUMAB FOR REFRACTORY CROHN'S DISEASE: A REGIONAL EXPERIENCE
    Mcgregor, Colleen
    Tarafdar, Adib
    Hussain, Moheez
    Griffiths, Cameron
    Chapman, Thomas
    Adams, Alex
    Wong, Darren
    Cripps, Sarah
    Brain, Oliver
    Ambrose, Timothy
    Palmer, Rebecca
    De Silva, Aminda
    Walsh, Alissa
    Travis, Simon
    Satsangi, Jack
    GUT, 2021, 70 : A108 - A108
  • [40] ANALYSIS OF EXPOSURE-OUTCOMES OF USTEKINUMAB IN PATIENTS WITH REFRACTORY CROHN'S DISEASE
    Yao, Jiayin
    Zhang, Min
    Liu, Tao
    Zhi, Min
    GUT, 2021, 70 : A103 - A103
12345